Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission

• Paul Griffin ,

  Contributed equally to this work with: Paul Griffin, Cielo Pasay

  Affiliations Clinical Tropical Medicine Laboratory, QIMR Berghofer, Brisbane, Australia, Q-Pharm Pty Ltd, Brisbane, Australia, Department of Medicine and Infectious Diseases, Mater Hospital and Mater Medical Research Institute, Brisbane, Australia, The University of Queensland, Brisbane, Australia

  ⨯
• Cielo Pasay ,

  Contributed equally to this work with: Paul Griffin, Cielo Pasay

  Affiliation Clinical Tropical Medicine Laboratory, QIMR Berghofer, Brisbane, Australia

  ⨯
• Suzanne Elliott,

  Affiliation Q-Pharm Pty Ltd, Brisbane, Australia

  ⨯
• Silvana Sekuloski,

  Affiliation Clinical Tropical Medicine Laboratory, QIMR Berghofer, Brisbane, Australia

  ⨯
• Maggy Sikulu,

  Affiliation Clinical Tropical Medicine Laboratory, QIMR Berghofer, Brisbane, Australia

  ⨯
• Leon Hugo,

  Affiliation Clinical Tropical Medicine Laboratory, QIMR Berghofer, Brisbane, Australia

  ⨯
• David Khoury,

  Affiliation University of New South Wales, Sydney, Australia

  ⨯
• Deborah Cromer,

  Affiliation University of New South Wales, Sydney, Australia

  ⨯
• Miles Davenport,

  Affiliation University of New South Wales, Sydney, Australia

  ⨯
• Jetsumon Sattabongkot,

  Affiliation Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Karen Ivinson,

  Affiliation PATH, Malaria Vaccine Initiative, Washington, DC, United States

  ⨯
• Christian Ockenhouse,

  Affiliation PATH, Malaria Vaccine Initiative, Washington, DC, United States

  ⨯
• James McCarthy

  * E-mail: j.mccarthy@uq.edu.au

  Affiliations Clinical Tropical Medicine Laboratory, QIMR Berghofer, Brisbane, Australia, The University of Queensland, Brisbane, Australia

  ⨯